POSTPROGRESSION SURVIVAL AND MRI FEATURES AT PROGRESSION IN MGMT-METHYLATED GLIOBLASTOMA FOLLOWING TEMOZOLOMIDE (TMZ) OR CCNU/TMZ THERAPY - AN ANALYSIS OF THE CETEG/NOA-09-TRIAL

被引：0

作者：

Zeyen, Thomas ^{[1
]}

Paech, Daniel ^{[2
]}

Weller, Johannes ^{[1
]}

Schaefer, Niklas ^{[1
]}

Tzaridis, Theophilos ^{[3
]}

Duffy, Cathrina ^{[4
]}

Nitsch, Louisa ^{[4
]}

Schneider, Matthias ^{[5
]}

Steinbach, Joachim ^{[6
]}

Hau, Peter ^{[7
]}

Schlegel, Uwe ^{[8
]}

Seidel, Clemens ^{[9
]}

Krex, Dietmar ^{[10
]}

Grauer, Oliver ^{[11
]}

Goldbrunner, Roland ^{[12
,13
]}

Zeiner, Pia ^{[6
]}

Tabatabai, Ghazaleh ^{[14
]}

Galldiks, Norbert ^{[13
,15
]}

Stummer, Walter ^{[16
]}

Hattingen, Elke ^{[17
]}

Tabatabai, Ghazaleh ^{[14
]}

Galldiks, Norbert ^{[13
,15
]}

Stummer, Walter ^{[16
]}

Hattingen, Elke ^{[17
]}

Glas, Martin ^{[18
,19
]}

Radbruch, Alexander ^{[2
]}

Herrlinger, Ulrich ^{[1
]}

Schaub, Christina ^{[1
]}

机构：

[1] Univ Hosp Bonn, Dept Neurol, Div Neurooncol, Bonn, Germany

[2] Univ Hosp Bonn, Dept Neuroradiol, Bonn, Germany

[3] Sanford Brunham Prebys, La Jolla, CA USA

[4] Univ Hosp Bonn, Div Neurooncol, Bonn, Germany

[5] Univ Hosp Bonn, Dept Neurosurg, Bonn, Germany

[6] Dr Senckenberg Inst Neurooncol, Frankfurt, Germany

[7] Univ Klinikum Regensburg, Regensburg, Germany

[8] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus, Dept Neurol, Bochum, Germany

[9] Univ Hosp Leipzig, Dept Radiotherapy, Leipzig, Germany

[10] Neurooncol Dresden, Dresden, Germany

[11] Univ Hosp Munster, Inst Translat Neurol, Dept Neurol, Munster, Germany

[12] Univ Cologne, Fac Med, Dept Gen Neurosurg, Cologne, Germany

[13] Univ Cologne, Univ Hosp Cologne, Cologne, Germany

[14] Univ Hosp Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Interdisciplinary Neuroonco, Tubingen, Germany

[15] Univ Cologne, Fac Med, Dept Neurol, Cologne, Germany

[16] Munster Univ Hosp, Dept Neurosurg, Munster, Germany

[17] Univ Hosp Frankfurt, Inst Neuroradiol, Frankfurt, Germany

[18] Univ Duisburg Essen, Univ Med Essen, Dept Neurol, Essen, Germany

[19] Univ Duisburg Essen, Univ Med Essen, Ctr Translat Neuro & Behav Sci C TNBS, Div Clin Neurooncol, Essen, Germany

来源：

NEURO-ONCOLOGY | 2022年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-32

引用

页码：169 / 170

页数：2

共 14 条

[1] PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial
Herrlinger, Ulrich
Tzaridis, Theophilos
Mack, Frederic
Steinbach, Joachim
Schlegel, Uwe
Sabel, Michael
Hau, Peter
Kortman, Rolf-Dieter
Krex, Dietmar
Grauer, Oliver
Goldbrunner, Roland
Schnell, Oliver
Baehr, Oliver
Uhl, Martin
Tabatabai, Ghazaleh
Ringel, Florian
Schmidt-Graf, Friederike
Brehmer, Stefanie
Weyerbrock, Astrid
Bullinger, Lars
Vajkoczy, Peter
Vatter, Hartmut
Schaefer, Niklas
Kebir, Sied
Weller, Johannes
Stummer, Walter
Simon, Matthias
Keil, Vera
Nelles, Michael
Fimmers, Rolf
Pietsch, Torsten
Hattingen, Elke
Coch, Christoph
Glas, Martin
NEURO-ONCOLOGY, 2017, 19 : 13 - 14
[2] QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA
Weller, Johannes
Tzaridis, Theophilos
Steinbach, Joachim
Schlegel, Uwe
Hau, Peter
Krex, Dietmar
Grauer, Oliver
Goldbrunner, Roland
Baehr, Oliver
Uhl, Martin
Seidel, Clemens
Tabatabai, Ghazaleh
Bullinger, Lars
Galldiks, Norbert
Schaub, Christina
Stummer, Walter
Simon, Matthias
Fimmers, Rolf
Matthias, Schmid
Coch, Christoph
Glas, Martin
Herrlinger, Ulrich
Schaefer, Niklas
NEURO-ONCOLOGY, 2018, 20 : 218 - 219
[3] MGMT PROMOTER METHYLATION ANALYSIS FOR ALLOCATING COMBINED CCNU/TMZ CHEMOTHERAPY: LESSONS LEARNED FROM THE CeTeG/NOA-09 TRIAL
Tzaridis, Theophilos
Schaefer, Niklas
Weller, Johannes
Steinbach, Joachim
Seidel, Sabine
Schlegel, Uwe
Sabel, Michael
Hau, Peter
Seidel, Clemens
Krex, Dietmar
Goldbrunner, Roland
Tonn, Joerg-Christian
Grauer, Oliver
Schaub, Christina
Coch, Christoph
Glas, Martin
Pietsch, Torsten
Fimmers, Rolf
Reifenberger, Guido
Felsberg, Joerg
Herrlinger, Ulrich
NEURO-ONCOLOGY, 2019, 21 : 25 - 26
[4] MGMT promoter methylation analysis for allocating combined CCNU/TMZ chemotherapy: Lessons learned from the CeTeG/NOA-09 trial
Tzaridis, Theophilos
Schaefer, Niklas
Weller, Johannes
Steinbach, Joachim-Peter
Schlegel, Uwe
Seidel, Sabine
Sabel, Michael
Hau, Peter
Seidel, Clemens
Krex, Dietmar
Goldbrunner, Roland
Tonn, Joerg-Christian
Grauer, Oliver
Kebir, Sied
Schneider, Matthias
Schaub, Christina
Vatter, Hartmut
Coch, Christoph
Glas, Martin
Fimmers, Rolf
Pietsch, Torsten
Reifenberger, Guido
Herrlinger, Ulrich
Felsberg, Joerg
INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (07) : 1695 - 1707
[5] Lomustine and temozolomide for newly diagnosed glioblastoma with methylated MGMT promoter: Lessons from the CeTeG/NOA-09 trial
Tremont-Lukats, Ivo W.
Teh, Bin S.
TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S589 - S591
[6] LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT
Weller, Johannes
Zeyen, Thomas
Schlegel, Uwe
Lazaridis, Lazaros
Werner, Jan-Michael
Onken, Julia
Zeiner, Pia
Drexler, Richard
Hau, Peter
Seidel, Clemens
Grosse, Lucia
Clusmann, Hans
Sabel, Michael
Ringel, Florian
Pichler, Josef
Grauer, Oliver
Hundsberger, Thomas
Schnell, Oliver
Mair, Maximilian J.
Uhl, Martin
Schmidt-Graf, Friederike
Glas, Martin
Galldiks, Norbert
Unteroberdoerster, Meike
Steinbach, Joachim
Ricklefs, Franz
Renovanz, Mirjam
Delev, Daniel Ivanov
Turgut, Merih O.
Flesch, Oliver R.
Cipriani, Debora
Preusser, Matthias
Kebir, Sied
Misch, Martin
Goldbrunner, Roland
Westphal, Manfred
Tabatabai, Ghazaleh
Schaefer, Niklas
Schneider, Matthias
Vatter, Hartmut
Giordano, Frank
Schaub, Christina
Herrlinger, Ulrich
NEURO-ONCOLOGY, 2022, 24 : 71 - 71
[7] Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Herrlinger, Ulrich
Tzaridis, Theophilos
Mack, Frederic
Steinbach, Joachim Peter
Schlegel, Uwe
Sabel, Michael
Hau, Peter
Kortmann, Rolf-Dieter
Krex, Dietmar
Grauer, Oliver
Goldbrunner, Roland
Schnell, Oliver
Baehr, Oliver
Uhl, Martin
Seidel, Clemens
Tabatabai, Ghazaleh
Kowalski, Thomas
Ringel, Florian
Schmidt-Graf, Friederike
Suchorska, Bogdana
Brehmer, Stefanie
Weyerbrock, Astrid
Renovanz, Miriam
Bullinger, Lars
Galldiks, Norbert
Vajkoczy, Peter
Misch, Martin
Vatter, Hartmut
Stuplich, Moritz
Schaefer, Niklas
Kebir, Sied
Weller, Johannes
Schaub, Christina
Stummer, Walter
Tonn, Joerg-Christian
Simon, Matthias
Keil, Vera C.
Nelles, Michael
Urbach, Horst
Coenen, Martin
Wick, Wolfgang
Weller, Michael
Fimmers, Rolf
Schmid, Matthias
Hattingen, Elke
Pietsch, Torsten
Coch, Christoph
Glas, Martin
LANCET, 2019, 393 (10172): : 678 - 688
[8] Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
Das, Sunit
Sahgal, Arjun
Perry, James R.
FRONTIERS IN ONCOLOGY, 2020, 10
[9] Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Weller, Johannes
Tzaridis, Theophilos
Mack, Frederic
Steinbach, Joachim Peter
Schlegel, Uwe
Hau, Peter
Krex, Dietmar
Grauer, Oliver
Goldbrunner, Roland
Baehr, Oliver
Uhl, Martin
Seidel, Clemens
Tabatabai, Ghazaleh
Brehmer, Stefanie
Bullinger, Lars
Galldiks, Norbert
Schaub, Christina
Kebir, Sied
Stummer, Walter
Simon, Matthias
Fimmers, Rolf
Coch, Christoph
Glas, Martin
Herrlinger, Ulrich
Schaefer, Niklas
LANCET ONCOLOGY, 2019, 20 (10): : 1444 - 1453
[10] Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy—the MecMeth/NOA-24 trial
Thomas Zeyen
Anna-Laura Potthoff
Robert Nemeth
Dieter H. Heiland
Michael C. Burger
Joachim P. Steinbach
Peter Hau
Ghazaleh Tabatabai
Martin Glas
Uwe Schlegel
Oliver Grauer
Dietmar Krex
Oliver Schnell
Roland Goldbrunner
Michael Sabel
Niklas Thon
Daniel Delev
Hans Clusmann
Clemens Seidel
Erdem Güresir
Matthias Schmid
Patrick Schuss
Frank A. Giordano
Alexander Radbruch
Albert Becker
Johannes Weller
Christina Schaub
Hartmut Vatter
Judith Schilling
Frank Winkler
Ulrich Herrlinger
Matthias Schneider
Trials, 23

← 1 2 →